Sort
82,697 grants matching “vaccine development”
Specific Pathogen Free 18 Baboon Research Resource (SPF18BRR)
$1,274,599William D Hopkins · University Of Tx Md Anderson Can Ctr · P40 · FY2025 · OD
Specific Pathogen Free 18 Baboon Research Resource (SPF18BRR)
$1,274,599Joe H. Simmons · University Of Tx Md Anderson Can Ctr · P40 · FY2024 · OD
The "Dynamics of the immune responses to repeat influenza vaccination exposures" (DRIVE) Study
$1,274,523Sarah Cobey · University Of Chicago · U01 · FY2024 · AI
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever
$1,274,067Jeffrey Meshulam · Profectus Biosciences, Inc. · N01 · FY2019 · AI
The Miami Center for AIDS Research
$1,273,977Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2016 · AI
Cornell Clinical Trials Unit
$1,273,956Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2013 · AI
T Cell Immune Responses To HIV And Other Pathogens
$1,273,880Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Tfh and B cells in HIV/SIV pathogenesis and vaccination
$1,273,880Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Tfh and B cells in HIV/SIV pathogenesis and vaccination
$1,273,880Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
T Cell Immune Responses To HIV And Other Pathogens
$1,273,880Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
HIV/SIV Replication In Vivo
$1,273,878Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
HIV/SIV Replication In Vivo
$1,273,878Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
HIV/SIV Replication In Vivo
$1,273,878Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Malaria parasite and vector genomics: transmission, pathology, and therapeutics
$1,273,577Daniel E Neafsey · Broad Institute, Inc. · U19 · FY2015 · AI
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
$1,273,323Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2024 · AI
Administrative Core
$1,273,196David Mitchell Smith · University Of California, San Diego · P30 · FY2022 · AI
Wirelessly controlled BSL3 vivarium system for automated microdosing in studies of infectious diseases
$1,273,102Tuan Q Hoang · Fluid Synchrony, Llc · R44 · FY2021 · OD
CHEMOKINE ADJUVANTS FOR BIOTHREAT PATHOGEN VACCINES
$1,273,008Chemocentryx, Inc. · U19 · FY2003 · AI
Vaccine Research and Development for Endemic, Emerging, and Resurgent Viruses
$1,272,981Masaru Kanekiyo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Animal Medicine COVID Support
$1,272,902Ruth Woodward · National Institute Of Allergy And Infectious Diseases · ZIG · FY2022 · AI
Synthetic Vaccine Against Human Pathogenic Bacteria
$1,272,803Vince Pozsgay · Child Health And Human Development · Z01 · FY2007 · HD
Human Respiratory Syncytial Virus Biology And Vaccine Development
$1,272,696Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
IND-enabling Preclinical Studies on Anti-Tau AD Vaccine for Phase 1 Trial
$1,272,333Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2020 · AG
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
$1,272,291Barton F Haynes · Duke University · U19 · FY2018 · AI
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever
$1,272,259Matthias Schnell · Thomas Jefferson University · N01 · FY2021 · AI